Inovio Pharmaceuticals, Inc. Q3 EPS $(0.25) Beats $(0.26) Estimate, Sales $866.863K Does Not Compare To $3.93M Estimate

Inovio Pharmaceuticals, Inc. (AMEX:INO) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 7.41 percent increase over losses of $(0.27) per

Benzinga · 11/12/2019 21:11

Inovio Pharmaceuticals, Inc. (AMEX:INO) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 7.41 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $866.863 thousand which missed the analyst consensus estimate of $3.93 million by 77.94 percent. This is a 56.68 percent decrease over sales of $2.001 million the same period last year.